Literature DB >> 22158922

Long-term follow-up after treatment of intracranial aneurysms with the Pipeline embolization device: results from a single center.

H A Deutschmann1, M Wehrschuetz, M Augustin, K Niederkorn, G E Klein.   

Abstract

BACKGROUND AND
PURPOSE: Stent-like, self-expandable devices, the so-called flow diverters, are increasingly used for the treatment of wide-neck cerebral aneurysms. The immediate and short-term results are promising, but no long-term results are available. The purpose of our research was to report the long-term angiographic and cross-sectional imaging results after placement of a PED in 12 patients with wide-neck intracranial aneurysms.
MATERIALS AND METHODS: Twelve wide-neck or otherwise untreatable cerebral aneurysms in 12 patients were treated with the PED. Angiography was performed at 6 and 24 months after treatment. Additional MR and CT angiograms were acquired.
RESULTS: In all patients, angiographic or cross-sectional imaging follow-up of at least 27 months demonstrated complete occlusion of the aneurysms treated with the PED. There were no cases of aneurysm recurrence. Angiography at around 6 months showed complete occlusion in all cases, except 1 that showed complete occlusion at the 29-month follow-up. In 1 patient, a clinically asymptomatic 75% in-stent stenosis was seen on the angiography at 6 months but was resolved completely by balloon dilation. Device placement was successful in all patients. Distal embolization had occurred in 1 patient, but the clot was resolved completely without clinical sequelae. Almost immediate angiographic occlusion was achieved in 2 aneurysms and flow reduction in 10 aneurysms.
CONCLUSIONS: Treatment of wide-neck intracranial aneurysms by PED placement led to successful and durable occlusion in all cases, without severe complications. Endovascular treatment for in-stent stenosis should be considered cautiously, because the underlying stenosis may be transient and disappear within 12 months after treatment.

Entities:  

Mesh:

Year:  2011        PMID: 22158922      PMCID: PMC7966428          DOI: 10.3174/ajnr.A2790

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

1.  Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen.

Authors:  P H Grewe; T Deneke; A Machraoui; J Barmeyer; K M Müller
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

2.  Early fatal hemorrhage after endovascular cerebral aneurysm treatment with a flow diverter (SILK-Stent): do we need to rethink our concepts?

Authors:  Bernd Turowski; Stephan Macht; Zolt Kulcsár; Daniel Hänggi; Walter Stummer
Journal:  Neuroradiology       Date:  2010-03-26       Impact factor: 2.804

3.  A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms.

Authors:  D F Kallmes; Y H Ding; D Dai; R Kadirvel; D A Lewis; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-15       Impact factor: 3.825

4.  Very late thrombosis of a pipeline embolization device construct: case report.

Authors:  David Fiorella; Daniel Hsu; Henry H Woo; Robert W Tarr; Peter Kim Nelson
Journal:  Neurosurgery       Date:  2010-09       Impact factor: 4.654

5.  Three-year follow-up after implantation of metallic coronary-artery stents.

Authors:  T Kimura; H Yokoi; Y Nakagawa; T Tamura; S Kaburagi; Y Sawada; Y Sato; H Yokoi; N Hamasaki; H Nosaka
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

6.  Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device.

Authors:  I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

7.  Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients.

Authors:  Shuichi Suzuki; Satoshi Tateshima; Reza Jahan; Gary R Duckwiler; Yuichi Murayama; Nestor R Gonzalez; Fernando Viñuela
Journal:  Neurosurgery       Date:  2009-05       Impact factor: 4.654

8.  Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils.

Authors:  Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

9.  Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience.

Authors:  Pedro Lylyk; Carlos Miranda; Rosana Ceratto; Angel Ferrario; Esteban Scrivano; Hugh Ramirez Luna; Aaron L Berez; Quang Tran; Peter K Nelson; David Fiorella
Journal:  Neurosurgery       Date:  2009-04       Impact factor: 4.654

10.  A new endoluminal, flow-disrupting device for treatment of saccular aneurysms.

Authors:  David F Kallmes; Yong Hong Ding; Daying Dai; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft
Journal:  Stroke       Date:  2007-07-05       Impact factor: 7.914

View more
  24 in total

1.  Small pipes: preliminary experience with 3-mm or smaller pipeline flow-diverting stents for aneurysm repair prior to regulatory approval.

Authors:  A R Martin; J P Cruz; C O'Kelly; M Kelly; J Spears; T R Marotta
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-13       Impact factor: 3.825

Review 2.  Endovascular treatment of cerebral aneurysms using flow-diverter devices: A systematic review.

Authors:  Francesco Briganti; Giuseppe Leone; Mariano Marseglia; Giuseppe Mariniello; Ferdinando Caranci; Arturo Brunetti; Francesco Maiuri
Journal:  Neuroradiol J       Date:  2015-08-27

3.  Periprocedural safety of Pipeline therapy for unruptured cerebral aneurysms: Analysis of 279 Patients in a multihospital database.

Authors:  Robert J McDonald; Jennifer S McDonald; David F Kallmes; Giuseppe Lanzino; Harry J Cloft
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

4.  The feasibility and efficacy of endovascular treatment for very small or tiny ruptured paraclinoid aneurysms.

Authors:  Jing Xu; Xian-Yi Chen; Ding-Yao Jiang; Wen Li; Jian-Min Zhang
Journal:  Neuroradiology       Date:  2012-08-09       Impact factor: 2.804

5.  What's coming down the pipe--and should we be excited, concerned, or both?

Authors:  J L Brisman
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-22       Impact factor: 3.825

6.  Long-Term Follow-Up Results following Elective Treatment of Unruptured Intracranial Aneurysms with the Pipeline Embolization Device.

Authors:  A H Y Chiu; A K Cheung; J D Wenderoth; L De Villiers; H Rice; C C Phatouros; T P Singh; T J Phillips; W McAuliffe
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-21       Impact factor: 3.825

7.  Patency of the anterior choroidal artery after flow-diversion treatment of internal carotid artery aneurysms.

Authors:  W Brinjikji; D F Kallmes; H J Cloft; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-22       Impact factor: 3.825

8.  A new-generation, low-permeability flow diverting device for treatment of saccular aneurysms.

Authors:  Ajit S Mallik; Katja Nuss; Peter W Kronen; Karina Klein; Agnieszka Karol; Brigitte von Rechenberg; Daniel A Rüfenacht; Isabel Wanke; Zsolt Kulcsár
Journal:  Eur Radiol       Date:  2013-07-24       Impact factor: 5.315

9.  Entry remnants in flow-diverted aneurysms: Does branch geometry influence aneurysm closure?

Authors:  M Akli Zetchi; Adam A Dmytriw; Albert H Chiu; Brian J Drake; Niki V Alizadeh; Aditya Bharatha; Abhaya V Kulkarni; Thomas R Marotta
Journal:  Interv Neuroradiol       Date:  2018-06-05       Impact factor: 1.610

10.  Extra-aneurysmal flow modification following pipeline embolization device implantation: focus on regional branches, perforators, and the parent vessel.

Authors:  G Gascou; K Lobotesis; H Brunel; P Machi; C Riquelme; O Eker; A Bonafé; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.